BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11224705)

  • 1. Biology and management of idiopathic myelofibrosis.
    Smith BD; Moliterno AR
    Curr Opin Oncol; 2001 Mar; 13(2):91-4. PubMed ID: 11224705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic myelofibrosis.
    Barosi G; Hoffman R
    Semin Hematol; 2005 Oct; 42(4):248-58. PubMed ID: 16210038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplant strategies for idiopathic myelofibrosis.
    McCarty JM
    Semin Hematol; 2004 Apr; 41(2 Suppl 3):23-9. PubMed ID: 15190520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
    Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
    Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complete regression of bone marrow fibrosis following allogeneic peripheral blood stem cell transplantation in a patient with idiopathic myelofibrosis].
    Benesová P; Dĕdic K; Zák P; Voglová J
    Cesk Patol; 2004 Oct; 40(4):167-71. PubMed ID: 15645853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sequential histological study of bone marrow fibrosis in idiopathic myelofibrosis.
    Hasselbalch H; Lisse I
    Eur J Haematol; 1991 May; 46(5):285-9. PubMed ID: 2044723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD34+ stem cells in chronic myeloproliferative disorders.
    Thiele J; Kvasnicka HM
    Histol Histopathol; 2002 Apr; 17(2):507-21. PubMed ID: 11962756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic myelofibrosis: historical review, diagnosis and management.
    Weinstein IM
    Blood Rev; 1991 Jun; 5(2):98-104. PubMed ID: 1912760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of severe bone marrow fibrosis and osteosclerosis following allogeneic bone marrow transplantation for chronic granulocytic leukaemia.
    McGlave PB; Brunning RD; Hurd DD; Kim TH
    Br J Haematol; 1982 Oct; 52(2):189-94. PubMed ID: 6751377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies.
    Zahr AA; Salama ME; Carreau N; Tremblay D; Verstovsek S; Mesa R; Hoffman R; Mascarenhas J
    Haematologica; 2016 Jun; 101(6):660-71. PubMed ID: 27252511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenic pooling and loss of VCAM-1 causes an engraftment defect in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation.
    Hart C; Klatt S; Barop J; Müller G; Schelker R; Holler E; Huber E; Herr W; Grassinger J
    Haematologica; 2016 Nov; 101(11):1407-1416. PubMed ID: 27662011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF) - a clinicopathological study.
    Thiele J; Kvasnicka HM; Boeltken B; Zankovich R; Diehl V; Fischer R
    Leukemia; 1999 Nov; 13(11):1741-8. PubMed ID: 10557047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
    Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
    J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extramedullary blast transformation in the central nervous system in idiopathic myelofibrosis.
    Barnes HM; Prchal JT; Scott CW
    Am J Hematol; 1981 Nov; 11(3):305-8. PubMed ID: 7315844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis.
    Pizzi M; Gergis U; Chaviano F; Orazi A
    Hematol Oncol Stem Cell Ther; 2016 Sep; 9(3):96-104. PubMed ID: 27521149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute myelofibrosis.
    Rupani M
    Am J Clin Pathol; 1982 Apr; 77(4):475-8. PubMed ID: 6951405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic myelofibrosis with nodal, serosal and parenchymatous infiltration. Case report and review of the literature.
    Tzankov A; Krugmann J; Steurer M; Dirnhofer S
    Acta Haematol; 2002; 107(3):173-6. PubMed ID: 11978939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis.
    Thiele J; Kvasnicka HM; Zankovich R; Diehl V
    Ann Hematol; 2001 Mar; 80(3):160-5. PubMed ID: 11320901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myeloproliferative disorders].
    Binder D; Fehr J
    Ther Umsch; 2004 Feb; 61(2):131-42. PubMed ID: 15018396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reversal of myelofibrosis associated with chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Oblon DJ; Elfenbein GJ; Braylan RC; Jones J; Weiner RS
    Exp Hematol; 1983 Aug; 11(7):681-5. PubMed ID: 6350032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.